Condition: Chemotherapy-induced Peripheral Neuropathy · Taxane-Induced Peripheral Neuropathy · CIPN - Chemotherapy-Induced Peripheral Neuropathy · Sponsor: Dana-Farber Cancer Institute
This study aims to evaluate the effectiveness, tolerability, and safety of using cooling therapy and pressure (cryocompression) to reduce peripheral neuropathy, a condition affecting the nerves supplying the arms and legs (limbs) resulting in possible numbness, pain, and/or loss of motor function, that may occur as a result of taxane-based chemotherapy. The name of the device used in this research study is: -Paxman Limb Cryocompression System (PLCS)
This description comes directly from the study's public registry record.
Theresa Jabaley Leonarczyk, PhD, RN · 617-582-8037 · theresa_jabaley@dfci.harvard.edu
Jabaley Leonarczyk, PhD, RN · 617-582-8037 · theresa_jabaley@dfci.harvard.edu
Always discuss trial participation with your own doctor first.
| Dana-Farber Cancer Institute | Boston, Massachusetts, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07064798